FR2789269A1 - Dietetic composition, useful for preventing cancer of intestine and colon, comprises food fiber and red fruit extract containing anthocyanosides - Google Patents
Dietetic composition, useful for preventing cancer of intestine and colon, comprises food fiber and red fruit extract containing anthocyanosides Download PDFInfo
- Publication number
- FR2789269A1 FR2789269A1 FR9901662A FR9901662A FR2789269A1 FR 2789269 A1 FR2789269 A1 FR 2789269A1 FR 9901662 A FR9901662 A FR 9901662A FR 9901662 A FR9901662 A FR 9901662A FR 2789269 A1 FR2789269 A1 FR 2789269A1
- Authority
- FR
- France
- Prior art keywords
- red fruit
- fruit extract
- extract
- dietetic composition
- dietary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Description
i COMPOSITION DIETETIQUE A BASE D'EXTRAIT(S) DE FRUITi DIETETIC COMPOSITION BASED ON FRUIT EXTRACT (S)
ROUGE, PROCEDE DE FABRICATION ET UTILISATION DE LADITE COMPOSITION RED, MANUFACTURING METHOD AND USE OF SAID COMPOSITION
L'invention a pour objet une composition diététique à base d'extrait(s) de fruit rouge. Elle concerne également le procédé de fabrication, de même que The subject of the invention is a dietary composition based on extract (s) of red fruit. It also relates to the manufacturing process, as well as
l'utilisation de ladite composition. the use of said composition.
Dans la suite de la description et dans les revendications, on désigne par fruits rouges, les baies de sureaux (Sambucus nigra), les baies de cassis (Ribes In the following description and in the claims, the term “red fruits” means elderberries (Sambucus nigra), blackcurrant berries (Ribes
nigrum), les groseilles (Ribes rubrum), les mûres (Morus nigra), le raisin, et plus particulièrement les myrtilles (Vaccinium myrtillus et autres espèces du genre Vaccinium), sans toutefois que cette liste soit limitative.15 Il est connu que les fruits rouges sont riches en pigments appelés anthocyanosides, dont on a prouvé qu'ils avaient des propriétés sur le système circulatoire sanguin. Ils présentent en effet une action vasomotrice provenant d'une restauration ou d'une augmentation des flux ioniques au niveau des membranes20 cellulaires et plus particulièrement d'une modification du flux de calcium. En outre, ils améliorent les fonctionnements microvasculaires en agissant notamment sur la nigrum), currants (Ribes rubrum), blackberries (Morus nigra), grapes, and more particularly blueberries (Vaccinium myrtillus and other species of the genus Vaccinium), although this list is not exhaustive.15 It is known that red fruits are rich in pigments called anthocyanosides, which have been proven to have properties on the blood circulatory system. They in fact exhibit a vasomotor action originating from a restoration or an increase in ionic fluxes at the level of cell membranes and more particularly from a modification of the calcium flux. In addition, they improve microvascular functioning by acting in particular on the
perméabilité des capillaires, l'augmentation étant de cette manière une des premières manifestations du processus inflammatoire. permeability of the capillaries, the increase being in this way one of the first manifestations of the inflammatory process.
Par ailleurs, il est connu que les anthocyanosides exercent une action inhibitrice vis-à-vis de l'élastase, enzyme protéolytique pouvant intervenir dans la Furthermore, it is known that anthocyanosides exert an inhibitory action with respect to elastase, a proteolytic enzyme which can intervene in the
dégradation du tissu conjonctif et du collagène. breakdown of connective tissue and collagen.
Enfin, il a également été démontré que les anthocyanosides avaient une Finally, it has also been shown that anthocyanosides have a
activité antioxydante, antiagrégant plaquettaire et antiradicalaire importante. significant antioxidant, anti-platelet and anti-radical activity.
Ces propriétés ont été reconnues pour le traitement des troubles relatifs à la circulation rétinienne, mais aussi dans le traitement des troubles fonctionnels de la fragilité capillaire et des troubles visuels d'origine vasculaire.35 Ces propriétés ont également été mises en oeuvre dans le traitement de l'hespéranopie et de la myopie, dans les spécialités pharmaceutiques 2 commercialisées sous les marques DIFRAREL 100 et DIFRAREL E par les These properties have been recognized for the treatment of disorders relating to the retinal circulation, but also in the treatment of functional disorders of capillary fragility and visual disorders of vascular origin.35 These properties have also been used in the treatment of hesperanopia and myopia, in the pharmaceutical specialties 2 marketed under the brands DIFRAREL 100 and DIFRAREL E by
Laboratoires LEURQUIN MEDIOLANUM.LEURQUIN MEDIOLANUM Laboratories.
D'après les propriétés reconnues des anthocyanosides, le Demandeur a constaté que les extraits de fruits rouges contenant des anthocyanosides pouvaient être judicieusement mélangés avec des fibres alimentaires à courte chaîne, chacun de ces deux composants présentant un effet synergique et étant susceptibles d'agir notamment comme facteurs préventifs de la prolifération cancéreuse au niveau de l'intestin et du colon.10 Plus précisément, l'invention concerne une composition diététique à base d'extrait(s) de fruit rouge caractérisée en ce qu'elle comprend en mélange * des fibres alimentaires, Based on the recognized properties of anthocyanosides, the Applicant has found that extracts of red fruits containing anthocyanosides can be judiciously mixed with short-chain dietary fibers, each of these two components having a synergistic effect and being capable of acting in particular as preventive factors for cancerous proliferation in the intestine and the colon.10 More specifically, the invention relates to a dietary composition based on extract (s) of red fruit characterized in that it comprises a mixture * of dietary fiber,
* au moins, un extrait de fruit rouge renfermant des anthocyanosides. * at least one red fruit extract containing anthocyanosides.
Selon une première caractéristique de l'invention, les fibres alimentaires sont choisies dans le groupe comprenant l'inuline et les oligosaccharides, seuls ou According to a first characteristic of the invention, the dietary fibers are chosen from the group comprising inulin and oligosaccharides, alone or
en mélange.in mixture.
Les oligosaccharides sont obtenus par hydrolyse fractionnée de polyosides naturels et notamment de l'inuline, ou de lactose dans le cas des galacto- The oligosaccharides are obtained by fractional hydrolysis of natural polysaccharides and in particular of inulin, or of lactose in the case of galacto-
oligosaccharides. Avantageusement, les oligosaccharides sont choisis dans le groupe oligosaccharides. Advantageously, the oligosaccharides are chosen from the group
comprenant les fructo-oligosaccharides (FOS), les oligo-fructoses et les galacto- oligosaccharides. including fructo-oligosaccharides (FOS), oligo-fructoses and galacto-oligosaccharides.
Plus précisément, les oligosaccharides sont composés de 2 à 7 molécules et se divisent en trois classes principales: * les fructo- oligosaccharides (FOS) sont composés de 1 à 3 molécules de fructose liées à une molécule de saccharose; * les oligo-fructoses sont composés de 2 à 6 molécules de fructose liées à une molécule de glucose ou de 2 à 6 molécules de fructose liées à un fructose réducteur; * les galacto-oligosaccharides sont composés de 2 à 5 molécules de More precisely, oligosaccharides are composed of 2 to 7 molecules and are divided into three main classes: * fructo-oligosaccharides (FOS) are composed of 1 to 3 molecules of fructose linked to a molecule of sucrose; * oligo-fructoses are composed of 2 to 6 molecules of fructose linked to a glucose molecule or 2 to 6 molecules of fructose linked to a reducing fructose; * galacto-oligosaccharides are composed of 2 to 5 molecules of
galactose, liées à une molécule de glucose. galactose, linked to a glucose molecule.
Les propriétés de ces fibres ont largement été décrites. On leur attribue notamment un rôle dans l'augmentation de la motricité intestinale, du fait que ces fibres de faible poids moléculaire ne sont pas digérées dans l'intestin grêle, mais5 sont assimilées dans la partie terminale du colon. De plus, leur structure à courte chaîne présente l'avantage de ne provoquer aucune irritation de la paroi intestinale The properties of these fibers have been widely described. In particular, they are attributed a role in increasing intestinal motility, because these low molecular weight fibers are not digested in the small intestine, but are assimilated in the terminal part of the colon. In addition, their short chain structure has the advantage of not causing any irritation of the intestinal wall.
susceptible d'entraîner la libération de radicaux libres. likely to result in the release of free radicals.
Avantageusement, les oligosaccharides choisis sont des fructo- Advantageously, the oligosaccharides chosen are fructo-
oligosaccharides.oligosaccharides.
En effet, il est connu que les FOS restaurent la balance microbienne intestinale en accroissant la flore bifidogène. De plus, la flore bifidogène rétablie par la consommation de FOS provoque une diminution du pH intestinal, facteur qui15 paraît favorable à la prévention des cancers coliques. En outre, les FOS présentent des propriétés de rétention sélective de certains minéraux (calcium, zinc, cuivre) et Indeed, it is known that FOS restore the intestinal microbial balance by increasing the bifidogenic flora. In addition, the bifidogenic flora restored by the consumption of FOS causes a decrease in the intestinal pH, a factor which seems favorable to the prevention of colon cancer. In addition, FOS have selective retention properties of certain minerals (calcium, zinc, copper) and
d'assimilation contrôlée des triacyl glycérols et des phospholipides dans le sang. controlled assimilation of triacyl glycerols and phospholipids in the blood.
L'effet synergique des anthocyanosides et des FOS peut donc être identifié. The synergistic effect of anthocyanosides and FOS can therefore be identified.
Il semble en effet intéressant de combiner l'activité antiradicalaire et antioxydante des anthocyanosides à la capacité des FOS à restaurer la balance microbienne intestinale et à abaisser le pH intestinal. La composition diététique de l'invention peut ainsi être avantageusement utilisée, sans que ce soit limitatif, dans la prévention de la prolifération cancéreuse de l'intestin et du colon.25 It indeed seems interesting to combine the anti-free radical and antioxidant activity of anthocyanosides with the capacity of FOS to restore the intestinal microbial balance and to lower the intestinal pH. The dietary composition of the invention can thus be advantageously used, without being limiting, in the prevention of cancerous proliferation of the intestine and the colon.
L'extrait de fruits rouges entrant dans la composition diététique de l'invention est avantageusement un extrait de myrtilles. The extract of red fruits used in the dietary composition of the invention is advantageously an extract of blueberries.
En pratique, cet extrait de myrtilles peut se présenter sous toutes formes In practice, this extract of blueberries can come in all forms
sèches conventionnelles, et notamment sous forme de poudre. conventional dry, and in particular in powder form.
Bien entendu, l'extrait de myrtilles pourra avoir subi tout procédé de purification connu de l'homme du métier, de sorte à augmenter son titre en anthocyanosides.35 Of course, the bilberry extract may have undergone any purification process known to those skilled in the art, so as to increase its titer in anthocyanosides. 35
On utilisera avantageusement des extraits de myrtilles titrés de 0 à 100 % en monomères anthocyanosidiques ou de 0 à 100 % en complexe catécho- Advantageously, extracts of blueberries titrated from 0 to 100% in anthocyanoside monomers or from 0 to 100% in catecho- complex will be used.
anthocyanique. Dans une forme avantageuse, la composition diététique de l'invention comprend entre 0,1 et 30 % en poids d'extrait de fruit rouge. Pour une concentration inférieure à 0,1 % en poids d'extrait, on ne relève aucun effet synergique entre les anthocyanosides contenues dans l'extrait et les anthocyanin. In an advantageous form, the dietary composition of the invention comprises between 0.1 and 30% by weight of red fruit extract. For a concentration of less than 0.1% by weight of extract, there is no synergistic effect between the anthocyanosides contained in the extract and the
fibres alimentaires.dietary fiber.
Pour une concentration supérieure à 30 % en poids d'extrait, l'effet synergique obtenu reste constant, un surdosage n'apporte donc aucun bénéfice. For a concentration greater than 30% by weight of extract, the synergistic effect obtained remains constant, an overdose therefore brings no benefit.
Il est à souligner que l'extrait de myrtille et les FOS se présentent avantageusement sous toute forme sèche, qui garantit une stabilité optimale de It should be noted that the bilberry extract and the FOS are advantageously in any dry form, which guarantees optimal stability of
chacun des composés, et ainsi leur activité. each of the compounds, and thus their activity.
L'invention concerne également le procédé de fabrication de la The invention also relates to the method for manufacturing the
composition selon lequel à température ambiante, on mélange l'extrait de fruit rouge et les fibres alimentaires. composition according to which at room temperature, the red fruit extract and the dietary fibers are mixed.
Avant mélange, les anthocyanosides et les FOS sont tamisés. On obtient alors un mélange de poudres, qui peut être conditionné sous toutes formes sèches, Before mixing, the anthocyanosides and the FOS are sieved. A mixture of powders is then obtained, which can be packaged in all dry forms,
en sachets par exemple, ou être soumis à une étape de compression, de sorte à obtenir des comprimés. in sachets for example, or be subjected to a compression step, so as to obtain tablets.
L'invention et les avantages qui en découlent ressortiront mieux des exemples de réalisation suivants. The invention and the advantages which result therefrom will emerge more clearly from the following exemplary embodiments.
On prépare deux formulations diététiques conformes à l'invention dont la Two dietary formulations are prepared in accordance with the invention, the
composition est la suivante.composition is as follows.
Exemple IExample I
Composition à 4 % - 40 mg d'extrait de myrtilles - 1 g de fructo-oligosaccharides ou d'inuline Composition at 4% - 40 mg of blueberry extract - 1 g of fructo-oligosaccharides or inulin
Exemple 2Example 2
Composition à 15 % - 40 mg d'extrait de myrtilles - 2 g de fructo-oligosaccharides ou d'inuline Dans les deux exemples, on tamise préalablement les deux poudres. L'extrait anthocyanosidique de myrtilles est tamisé sur un seuil de coupure de 180 microns. En ce qui les concerne, les FOS sont tamisés sur un seuil de coupure de Composition at 15% - 40 mg of blueberry extract - 2 g of fructo-oligosaccharides or inulin In the two examples, the two powders are sieved beforehand. The anthocyanosidic extract of blueberries is sieved over a cutoff threshold of 180 microns. As far as they are concerned, the FOS are screened on a cutoff threshold of
710 micromètres.710 micrometers.
On effectue tout d'abord un prémélange en mélangeant la totalité de l'extrait de myrtilles avec la moitié de la quantité de FOS. Le mélange final est First, a premix is made by mixing all of the blueberry extract with half the amount of FOS. The final mixture is
obtenu en mélangeant le prémélange avec la seconde moitié de FOS. obtained by mixing the premix with the second half of FOS.
On conditionne ensuite le mélange ainsi obtenu sous forme de sachets étanches. Les conditions du mélange et du conditionnement, sous hygrométrie contrôlée et inférieure à 10 %, sont les facteurs essentiels pour garantir la stabilité The mixture thus obtained is then packaged in the form of sealed bags. The mixing and packaging conditions, under controlled humidity and below 10%, are the essential factors to guarantee stability
du produit, et donc son activité.of the product, and therefore its activity.
Les avantages de l'invention ressortent bien de la description. The advantages of the invention appear clearly from the description.
On notera en particulier l'effet synergique d'un extrait de fruit rouge riche en anthocyanosides et de fibres alimentaires, composés qui se positionnent notamment comme facteurs favorables à la prévention de la prolifération Note in particular the synergistic effect of a red fruit extract rich in anthocyanosides and dietary fibers, compounds which are positioned in particular as factors favorable to the prevention of proliferation
cancéreuse de l'intestin et du colon. intestinal and colon cancer.
On notera en outre la simplicité du procédé de fabrication de la Note also the simplicity of the manufacturing process of the
composition objet de l'invention.composition object of the invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9901662A FR2789269B1 (en) | 1999-02-09 | 1999-02-09 | DIETETIC COMPOSITION BASED ON RED FRUIT EXTRACT (S), MANUFACTURING METHOD AND USE OF SAID COMPOSITION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9901662A FR2789269B1 (en) | 1999-02-09 | 1999-02-09 | DIETETIC COMPOSITION BASED ON RED FRUIT EXTRACT (S), MANUFACTURING METHOD AND USE OF SAID COMPOSITION |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2789269A1 true FR2789269A1 (en) | 2000-08-11 |
FR2789269B1 FR2789269B1 (en) | 2001-06-15 |
Family
ID=9541914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9901662A Expired - Fee Related FR2789269B1 (en) | 1999-02-09 | 1999-02-09 | DIETETIC COMPOSITION BASED ON RED FRUIT EXTRACT (S), MANUFACTURING METHOD AND USE OF SAID COMPOSITION |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2789269B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004002238A1 (en) * | 2002-06-26 | 2004-01-08 | Nestec S.A. | Nutritional composition for detoxification and cancer prevention |
US20100323041A1 (en) * | 2002-08-30 | 2010-12-23 | Biopharmacopae Design International Inc. | Methods and therapeutic compositions comprising plant extracts for the treatment of cancer |
CN101297692B (en) * | 2008-05-26 | 2013-04-03 | 昆明理工大学 | Extraction of glycosides from Vaccinium dunalianum Wight var. dunalianum and use thereof in health products |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1984003216A1 (en) * | 1983-02-16 | 1984-08-30 | Carl Axel Virdalm | A preparation for suppressing states of illness in the digestive system |
JPS6343959A (en) * | 1986-08-11 | 1988-02-25 | San Ei Chem Ind Ltd | Method for stabilizing anthocyanin dye |
EP0573777A1 (en) * | 1992-05-11 | 1993-12-15 | INDENA S.p.A. | Oral pharmaceutical compositions containing anthocyanosides |
EP0692252A1 (en) * | 1994-06-14 | 1996-01-17 | "Raffinerie Tirlemontoise", société anonyme: | Composition containing inulin or oligofructose for use in cancer treatment |
-
1999
- 1999-02-09 FR FR9901662A patent/FR2789269B1/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1984003216A1 (en) * | 1983-02-16 | 1984-08-30 | Carl Axel Virdalm | A preparation for suppressing states of illness in the digestive system |
JPS6343959A (en) * | 1986-08-11 | 1988-02-25 | San Ei Chem Ind Ltd | Method for stabilizing anthocyanin dye |
EP0573777A1 (en) * | 1992-05-11 | 1993-12-15 | INDENA S.p.A. | Oral pharmaceutical compositions containing anthocyanosides |
EP0692252A1 (en) * | 1994-06-14 | 1996-01-17 | "Raffinerie Tirlemontoise", société anonyme: | Composition containing inulin or oligofructose for use in cancer treatment |
Non-Patent Citations (1)
Title |
---|
PATENT ABSTRACTS OF JAPAN vol. 012, no. 258 (C - 513) 20 July 1988 (1988-07-20) * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004002238A1 (en) * | 2002-06-26 | 2004-01-08 | Nestec S.A. | Nutritional composition for detoxification and cancer prevention |
AU2003280504B2 (en) * | 2002-06-26 | 2009-11-19 | Nestec S.A. | Nutritional composition for detoxification and cancer prevention |
US20100323041A1 (en) * | 2002-08-30 | 2010-12-23 | Biopharmacopae Design International Inc. | Methods and therapeutic compositions comprising plant extracts for the treatment of cancer |
CN101297692B (en) * | 2008-05-26 | 2013-04-03 | 昆明理工大学 | Extraction of glycosides from Vaccinium dunalianum Wight var. dunalianum and use thereof in health products |
Also Published As
Publication number | Publication date |
---|---|
FR2789269B1 (en) | 2001-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chew et al. | In-vitro evaluation of kenaf seed oil in chitosan coated-high methoxyl pectin-alginate microcapsules | |
EP1909593B1 (en) | Pea protein composition | |
JP4782104B2 (en) | Pecer derived from acerola fruit and its use | |
CA2895353A1 (en) | Prophylactic/therapeutic agent for dry eye | |
JP2008500027A (en) | Berry oil and products | |
DE102008032828A1 (en) | Tryptophan-containing peptides from alpha-lactalbumin with hypotensive and vasoprotective action for biofunctional foods | |
Nguyen et al. | Production of xyloglucan component extracted from tamarind (Tamarindus indica) seeds using microwave treatment for seed decortication | |
US20070237859A1 (en) | Drink containing functional ingredients capable of preventing degenerative phenomena caused by oxidizing agents | |
Pérez et al. | Interest of black carob extract for the development of active biopolymer films for cheese preservation | |
CA2666960A1 (en) | Ultra high pressure modified proteins and uses thereof | |
JP2004189698A (en) | Bleaching agent, antioxidant, collagenase inhibitor, hyaluronidase inhibitor, age resister, skin lotion, cosmetic and food | |
FR2789269A1 (en) | Dietetic composition, useful for preventing cancer of intestine and colon, comprises food fiber and red fruit extract containing anthocyanosides | |
FR2792831A1 (en) | COMPOSITION FOR COSMETIC AND / OR DIETETIC USE COMPRISING A MIXTURE OF LYCOPENE AND OLIVE LEAF EXTRACT | |
CA2359475A1 (en) | Method for purifying a red fruit extract containing anthocyanosides | |
EP2627192B1 (en) | Hydrolysates of animal proteins of marine origin with neuroprotective properties | |
KR101617320B1 (en) | Royal jelly beverage composition having improved dispersability in water and method for preparing the same | |
Wang et al. | Effects of glycation with chitooligosaccharide on digestion and fermentation processes of lactoferrin in vitro | |
EP1245580A1 (en) | Fibre containing composition for enteral nutrition | |
KR20210153178A (en) | Composition for promoting absorption of collagen and synthesis of collagen | |
WO1999065459A1 (en) | Cereal plant extract based on polar lipids | |
Cornelia et al. | Encapsulation of soursop (Annona muricata Linn.) leaf tea extract using natural mucilage | |
Ragazzo-Sánchez et al. | Utilization of by-products of endemic fruits: Encapsulation of proteolytic extracts of guamara (Bromelia pinguin) and cocuixtle (Bromelia karatas) by electrospraying | |
CA2123585A1 (en) | Polar lipidic composition from plants | |
CA2778170A1 (en) | Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent | |
JP2020152651A (en) | Novel salmon-derived proteoglycan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20091030 |